Last edition
News about "Competitive Generic Therapy (CGT) approval"
Zydus Gets US FDA Approval for Estradiol Patch
Zydus Lifesciences has received the US FDA approval for Estradiol and Levonorgestrel Transdermal System, eligible for 180-day CGT exclusivity.
Competitive Generic Therapy (CGT) Approval | 21/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members